Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

Journal of viral hepatitis - 1 Mar 2013

Petta S, Handberg A, Marchesini G, Cammà C, Di Marco V, Cabibi D, Macaluso F S, Craxì A

Abstract excerpt

Soluble CD36 (sCD36) plasma levels, a known marker of cardiometabolic disorders, are associated with surrogate markers of steatosis, while experimental and human studies show a link between CD36 expression in the liver and steatosis. In a cohort of patients with genotype 1 chronic hepatitis C (G1 CHC), we tested the association of sCD36 plasma levels with host and viral factors and sustained virological response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to CD36 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Fatty Liver

Share to Hepatitis C, Chronic

Share to Interferons

Share to Plasma

Share to Ribavirin

Source

Identifiers

PMID: 23383656
DOI: 10.1111/j.1365-2893.2012.01641.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.PMID 23383656Read ↗

Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.Semantic proximity Read ↗

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.Semantic proximity Read ↗

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C and steatosis.Semantic proximity Read ↗

Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.Semantic proximity Read ↗

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.Semantic proximity Read ↗

Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsSemantic proximity Read ↗

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.Semantic proximity Read ↗

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.Semantic proximity Read ↗

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.Semantic proximity Read ↗

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.